Literature DB >> 17941900

Novel melanocortin 4 receptor gene mutations in severely obese children.

Yung Seng Lee1, Larry Kok Seng Poh, Betty Lay Kee Kek, Kah Yin Loke.   

Abstract

OBJECTIVE: Melanocortin 4 receptor (MC4R) deficiency is the commonest monogenic form of obesity. The significance of MC4R mutations in Asian obese populations has not been adequately examined. The objective of this study was to determine the role of MC4R mutations in severely obese Asian children.
DESIGN: We screened 227 obese local children and adolescents for MC4R gene mutations by polymerase chain reaction and direct sequencing.
RESULTS: We identified three mutations in three subjects: 4 bp deletion from nucleotides 631-634 (c.631-634delCTCT), Tyr157Ser (c.470 A > C) and 1 bp deletion at nucleotide 976 (c.976delT) (1.32% of study subjects). The latter two mutations are novel. The Tyr157Ser mutation was not found in 188 non-obese controls using restriction enzyme digest analysis. In vitro transient transfection studies supported the pathogenic role of both novel mutations Tyr157Ser and c.976delT, where the signalling activities of the mutant receptors were impaired. Heterozygous MC4R mutations were associated with early-onset severe obesity, and homozygosity of the MC4R mutation Tyr157Ser resulted in morbid obesity.
CONCLUSION: MC4R mutations result in an autosomal codominant form of obesity with variable expressivity. MC4R deficiency is not as common among the obese children in this study compared to other populations. Family studies revealed that adults heterozygous for the mutations were less obese compared to the children. We hypothesize that this may be due to amelioration of phenotype severity with age, genetic anticipation or difference in exposure to modifying factors at critical stages of childhood such as the environment.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17941900     DOI: 10.1111/j.1365-2265.2007.03071.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  6 in total

1.  Melanocortin-4-receptor autoantibodies: a new player in obesity.

Authors:  Chandra Mohan; Anil K Agarwal
Journal:  J Clin Endocrinol Metab       Date:  2009-03       Impact factor: 5.958

2.  Pharmacological characterization of 30 human melanocortin-4 receptor polymorphisms with the endogenous proopiomelanocortin-derived agonists, synthetic agonists, and the endogenous agouti-related protein antagonist.

Authors:  Zhimin Xiang; Bettina Proneth; Marvin L Dirain; Sally A Litherland; Carrie Haskell-Luevano
Journal:  Biochemistry       Date:  2010-06-08       Impact factor: 3.162

3.  The melanocortin-4 receptor: physiology, pharmacology, and pathophysiology.

Authors:  Ya-Xiong Tao
Journal:  Endocr Rev       Date:  2010-02-26       Impact factor: 19.871

4.  Melanocortin-4 Receptor Gene Mutations in a Group of Turkish Obese Children and Adolescents.

Authors:  Selma Tunç; Korcan Demir; Fatma Ajlan Tükün; Cihan Topal; Filiz Hazan; Burcu Sağlam; Özlem Nalbantoğlu; Melek Yıldız; Behzat Özkan
Journal:  J Clin Res Pediatr Endocrinol       Date:  2017-02-20

5.  Unraveling the central proopiomelanocortin neural circuits.

Authors:  Aaron J Mercer; Shane T Hentges; Charles K Meshul; Malcolm J Low
Journal:  Front Neurosci       Date:  2013-02-22       Impact factor: 4.677

6.  Hypothalamic POMC deficiency increases circulating adiponectin despite obesity.

Authors:  Hui Yu; Kavaljit H Chhabra; Zoe Thompson; Graham L Jones; Sylee Kiran; Gary Shangguan; Malcolm J Low
Journal:  Mol Metab       Date:  2020-02-07       Impact factor: 7.422

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.